Using Bio-Plex Phosphoprotein Assays to Study EGFR Signaling in Human Patient-Derived Xenografts Treated with Cetuximab
10 Sep 2012

Cetuximab has been used to treat many advanced cancers, but is only effective in a fraction of patients. In this application note by Bio-Rad the Bio-Plex phosphoprotein assays were used to demonstrate that the effectiveness of cetuximab is not determined solely by its ability to inhibit EGFR activation.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!